U0126: Not only a MAPK kinase inhibitor
- PMID: 36091807
- PMCID: PMC9452634
- DOI: 10.3389/fphar.2022.927083
U0126: Not only a MAPK kinase inhibitor
Abstract
U0126, as an inhibitor of the MAPK signaling pathway, is closely related to various biological processes, such as differentiation, cell growth, autophagy, apoptosis, and stress responses. It makes U0126 play an essential role in balancing cellular homeostasis. Although U0126 has been suggested to inhibit various cancers, its complete mechanisms have not been clarified in cancers. This review summarized the most recent and relevant research on the many applications of U0126 and described its role and mechanisms in different cancer cell types. Moreover, some acknowledged functions of U0126 researched in the laboratory were listed in our review. We discussed the probability of using U0126 to restain cancers or suppress the MAPK pathway as a novel way of cancer treatment.
Keywords: MAPK inhibitors; MAPK signal pathway; U0126; cancer; cancer therapy.
Copyright © 2022 You, Niu, Zhang, Huang, Ding, Sun and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.Leukemia. 2002 Apr;16(4):683-92. doi: 10.1038/sj.leu.2402400. Leukemia. 2002. PMID: 11960350
-
Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.J Pediatr Surg. 2006 Jan;41(1):252-9. doi: 10.1016/j.jpedsurg.2005.10.047. J Pediatr Surg. 2006. PMID: 16410143
-
[Effects of targeting inhibition of ERK1/2 signal transduction pathway on malignant biological behaviors of human high-metastatic large cell lung cancer cell line L9981].Zhongguo Fei Ai Za Zhi. 2005 Dec 20;8(6):504-9. doi: 10.3779/j.issn.1009-3419.2005.06.04. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21208537 Chinese.
-
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression.Ann Transl Med. 2020 Oct;8(20):1305. doi: 10.21037/atm-20-5478. Ann Transl Med. 2020. PMID: 33209885 Free PMC article.
-
[Fission Yeast as a Model System for Studying Cancer Signaling and Drug Discovery: Discovery of ACA-28 as a Novel Inducer of ERK-dependent Apoptosis Reveals a New Cancer Therapy].Yakugaku Zasshi. 2019;139(5):753-758. doi: 10.1248/yakushi.18-00185-3. Yakugaku Zasshi. 2019. PMID: 31061345 Review. Japanese.
Cited by
-
Aggression Results in the Phosphorylation of ERK1/2 in the Nucleus Accumbens and the Dephosphorylation of mTOR in the Medial Prefrontal Cortex in Female Syrian Hamsters.Int J Mol Sci. 2023 Jan 10;24(2):1379. doi: 10.3390/ijms24021379. Int J Mol Sci. 2023. PMID: 36674893 Free PMC article.
-
The In Vitro Anti-Parasitic Activities of Emodin toward Toxoplasma gondii.Pharmaceuticals (Basel). 2023 Mar 16;16(3):447. doi: 10.3390/ph16030447. Pharmaceuticals (Basel). 2023. PMID: 36986545 Free PMC article.
-
Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis.Int J Mol Sci. 2024 Oct 4;25(19):10691. doi: 10.3390/ijms251910691. Int J Mol Sci. 2024. PMID: 39409019 Free PMC article.
-
MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer.Cells. 2023 Jul 23;12(14):1917. doi: 10.3390/cells12141917. Cells. 2023. PMID: 37508580 Free PMC article.
-
Applying a novel kinomics approach to study decidualization and the effects of antigestagens using a canine model†.Biol Reprod. 2024 Mar 13;110(3):583-598. doi: 10.1093/biolre/ioad170. Biol Reprod. 2024. PMID: 38079525 Free PMC article.
References
-
- Baines P., Fisher J Fau - Truran L., TruranFau - Davies L. E., Davies E Fau - Hallett M., Hallett M Fau - Hoy T., Hoy T Fau - Burnett A. K., et al. (2002). The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro . Eur. J. Haematol. 64, 211–218. 10.1034/j.1600-0609.2000.90139.x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources